These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 24183273)

  • 1. Analysis of adverse events with Essure hysteroscopic sterilization reported to the Manufacturer and User Facility Device Experience database.
    Al-Safi ZA; Shavell VI; Hobson DT; Berman JM; Diamond MP
    J Minim Invasive Gynecol; 2013; 20(6):825-9. PubMed ID: 24183273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Essure hysteroscopic sterilization--5 years follow up of 1200 women.
    Ríos-Castillo JE; Velasco E; Arjona-Berral JE; Monserrat Jordán JA; Povedano-Cañizares B; Castelo-Branco C
    Gynecol Endocrinol; 2013 Jun; 29(6):580-2. PubMed ID: 23557170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of complications encountered with Essure hysteroscopic sterilization: a systematic review.
    Adelman MR; Dassel MW; Sharp HT
    J Minim Invasive Gynecol; 2014; 21(5):733-43. PubMed ID: 24768959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Essure Permanent Birth Control, Effectiveness and Safety: An Italian 11-Year Survey.
    Franchini M; Zizolfi B; Coppola C; Bergamini V; Bonin C; Borsellino G; Busato E; Calabrese S; Calzolari S; Fantin GP; Giarrè G; Litta P; Luerti M; Mangino FP; Marchino GL; Molinari MA; Scatena E; Scrimin F; Telloli P; Di Spiezio Sardo A
    J Minim Invasive Gynecol; 2017; 24(4):640-645. PubMed ID: 28232037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of tubal patency after essure placement.
    Rodriguez AM; Kilic GS; Vu TP; Kuo YF; Breitkopf D; Snyder RR
    J Minim Invasive Gynecol; 2013; 20(4):468-72. PubMed ID: 23541247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient Outcomes Following Injury from Hysteroscopic Sterilization.
    Sills ES; Dalton MM
    Surg Technol Int; 2016 Apr; 28():165-9. PubMed ID: 27042777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placement of a permanent birth control device at a university medical center.
    Shavell VI; Abdallah ME; Diamond MP; Berman JM
    J Reprod Med; 2009 Apr; 54(4):218-22. PubMed ID: 19438163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in sterilization since the introduction of Essure hysteroscopic sterilization.
    Shavell VI; Abdallah ME; Shade GH; Diamond MP; Berman JM
    J Minim Invasive Gynecol; 2009; 16(1):22-7. PubMed ID: 18996773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Techniques for removal of the Essure hysteroscopic tubal occlusion device.
    Lannon BM; Lee SY
    Fertil Steril; 2007 Aug; 88(2):497.e13-4. PubMed ID: 17397840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated with Negative Patient Experiences with Essure Sterilization.
    van Limburg Stirum EVJ; Clark NV; Lindsey A; Gu X; Thurkow AL; Einarsson JI; Cohen SL
    JSLS; 2020; 24(1):. PubMed ID: 32206011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tubal sterilization: pregnancy rates after hysteroscopic versus laparoscopic sterilization in France, 2006-2010.
    Fernandez H; Legendre G; Blein C; Lamarsalle L; Panel P
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():133-7. PubMed ID: 24993770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technique for the Laparoscopic Removal of Essure Microinserts.
    Mahmoud MS
    J Minim Invasive Gynecol; 2016; 23(4):472. PubMed ID: 26776673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hysteroscopic morcellation: review of the manufacturer and user facility device experience (MAUDE) database.
    Haber K; Hawkins E; Levie M; Chudnoff S
    J Minim Invasive Gynecol; 2015 Jan; 22(1):110-4. PubMed ID: 25128851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placement of the Essure permanent birth control device with fluoroscopic guidance: a novel method for tubal sterilization.
    McSwain H; Shaw C; Hall LD
    J Vasc Interv Radiol; 2005 Jul; 16(7):1007-12. PubMed ID: 16002509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful pregnancy outcome with the use of in vitro fertilization after Essure hysteroscopic sterilization.
    Kerin JF; Cattanach S
    Fertil Steril; 2007 May; 87(5):1212.e1-4. PubMed ID: 17343857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hysteroscopic tubal sterilization (essure) in women with an intrauterine device.
    Agostini A; Crochet P; Petrakian M; Estrade JP; Cravello L; Gamerre M
    J Minim Invasive Gynecol; 2008; 15(3):277-9. PubMed ID: 18439497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial Asian experience in hysteroscopic sterilisation using the Essure permanent birth control device.
    Chern B; Siow A
    BJOG; 2005 Sep; 112(9):1322-7. PubMed ID: 16101615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hysteroscopic female sterilization with Essure in an outpatient setting.
    Andersson S; Eriksson S; Mints M
    Acta Obstet Gynecol Scand; 2009; 88(6):743-6. PubMed ID: 19412802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ICSI pregnancy outcomes following hysteroscopic placement of Essure devices for hydrosalpinx in laparoscopic contraindicated patients.
    Ozgur K; Bulut H; Berkkanoglu M; Coetzee K; Kaya G
    Reprod Biomed Online; 2014 Jul; 29(1):113-8. PubMed ID: 24813749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necessity of hysterosalpingography after Essure microinsert placement for contraception.
    Lazarus E; Lourenco AP; Casper S; Allen RH
    AJR Am J Roentgenol; 2012 Jun; 198(6):1460-3. PubMed ID: 22623563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.